NovaBay Pharmaceuticals To Present At The 2010 BIO CEO & Investor Conference

Main Category: Pharma Industry / Biotech Industry
Also Included In: Conferences
Article Date: 05 Feb 2010 - 18:00 PDT

email to a friend   printer friendly   opinions  

NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class, anti-infective compounds in the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the 12th Annual BIO CEO & Investor Conference on Tuesday, Feb. 9 in New York City.

Dr. Najafi's presentation will take place at 2:30 p.m. ET in the Duke of Windsor room at the Waldorf Astoria. His presentation will provide a corporate overview and highlight NovaBay's clinical progress in its internal programs, as well as in its partnered programs with Alcon (NYSE: ACL) and Galderma.

An audio of the presentation will be available on NovaBay's homepage at http://www.novabaypharma.com.

Source
NovaBay Pharmaceuticals

• Additional
• References
• Citations